STR_OPP_004

Distressed IP Value Capture

The acquisition of technically superior entities (IN05) that have suffered financial collapse due to poor capital management or high credit restrictions (FR06). The value lies in the 'Stripped IP' which can be integrated into a stable parent firm.

Strategic Alpha & Market Capture 3 Conditions 1 Playbook

Business Impact

IP Moat Expansion. Acquisition of technology at a 70-90% discount to R&D cost; neutralizing a future competitor while accelerating the parent's product roadmap.

Trigger Conditions

All conditions must be met to trigger this risk

IN05 R&D Burden & Innovation Tax
≥ 4 / 5

Hyper-Intensive: 15-25% Revenue. Survival depends on constant breakthroughs (e.g., Biotech, Semis).

FR06 Risk Insurability & Financial Access
≥ 4 / 5

Extreme Risk Surcharge: Insurance is punitive or available only through state-backed 'Insurers of Last Resort'; commercial banks largely avoid the sector/jurisdiction.

MD08 Structural Market Saturation
≤ 2 / 5

Balanced: Supply meets demand; growth aligns with GDP.

Mitigation Strategy

Use an Asset Purchase Agreement (APA) to avoid assuming legacy liabilities; focus on retaining key 'Knowledge Bearers' (CS08) during the transition.

Triggered Playbooks

1 playbook respond to this risk:

STR IP-Scavenge & Integration
3 steps

Risk Cascade

Rules can trigger other rules in a cascade effect:

Example Scenario

Biotech / Advanced Materials (ISIC 2100)

A startup with a breakthrough solid-state battery patent (IN05) runs out of cash during a credit crunch (FR06). A Tier-1 automotive firm acquires the IP portfolio out of liquidation for pennies on the dollar.

Matched Industries

1 industriy meets all conditions of this rule:

ISIC 7110 Architectural and engineering activities and related technical consultancy View scenario →